Early Corticosteroid use and Clinical Outcomes in Patients with Mixed and Cardiogenic Shock
Open Access
- 1 June 2026
- journal article
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 41 (11) , 1168-1177
Abstract
Background: The pathophysiology of CS is complex and is associated with increased inflammation and impaired vascular tone. Corticosteroids are recommended in septic shock and have been proposed as a potential treatment for other types of shock. Objectives: We sought to evaluate the clinical outcomes associated with early corticosteroid use in patients with cardiogenic shock (CS). Methods: Using a nationally representative database including over 1000 hospitals, we identified adults ≥18 years of age admitted from 2015–2023 with a diagnosis of CS. Patients with adrenal insufficiency, chronic rheumatologic conditions, COVID-19 infection and acute COPD exacerbation were excluded. Using inverse probability treatment weighting (IPTW), we assessed for the association of receiving early corticosteroids (within the first 2 days of admission) versus no early corticosteroids and in-hospital mortality. Results: Of the 167,721 identified patients with CS, the mean (SD) age was 65.5 (±15.2) years and 35.0% were women. A total of 13.2% received any corticosteroid within the first 2 days of admission. The most common corticosteroid was hydrocortisone (73.9%). Mortality for those receiving and not receiving early corticosteroids was 48.8% and 29.6% ( p < 0.001), respectively. After IPTW, early corticosteroid use remained associated with a 3.1% (95% confidence interval [CI]: 2.4% to 3.8%, p < 0.001) higher mortality. Among patients with CS and concomitant sepsis, 27.6% received early corticosteroids, which was similarly associated with a higher mortality (weighted mean 5.8% [95% CI: 4.6% to 7.0%, p < 0.001]). Conclusions: Approximately 1 in 7 patients with CS received corticosteroids early during their admission, which was associated with higher in-hospital mortality.Keywords
This publication has 21 references indexed in Scilit:
- Identifying biomarker-driven subphenotypes of cardiogenic shock: analysis of prospective cohorts and randomized controlled trialseClinicalMedicine, 2024
- Mixed Cardiogenic-Vasodilatory ShockJACC: Advances, 2024
- Serial Shock Severity Assessment Within 72 Hours After DiagnosisJACC, 2024
- Research Priorities in Critical Care CardiologyJACC, 2023
- Advances in the Staging and Phenotyping of Cardiogenic ShockJACC: Advances, 2022
- Cardiogenic shock elicits acute inflammation, delayed eosinophilia, and depletion of immune cells in most severe casesScientific Reports, 2020
- Hydrocortisone plus Fludrocortisone for Adults with Septic ShockNew England Journal of Medicine, 2018
- Adjunctive Glucocorticoid Therapy in Patients with Septic ShockNew England Journal of Medicine, 2018
- Constructing Inverse Probability Weights for Marginal Structural ModelsAmerican Journal of Epidemiology, 2008
- Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative DataMedical Care, 2005